Q32 Bio(QTTB.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Q32 Bio
QTTB.US
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti–interleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb – CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
1.880 T
QTTB.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    "Hong Kong Stocks" The Hang Seng Index fell 265 points in the first half of the day, some AI stocks and pharmaceutical stocks retreated, while power equipment stocks surged

    The Hong Kong stock market fell in early trading, with the Hang Seng Index down 265 points, reporting at 26,579 points. The National Index fell 77 points, and the Hang Seng Tech Index dropped 66 points. The total turnover was HKD 132.94 billion. Smartphone manufacturers like Xiaomi lowered their shipment expectations, leading to a decline in related stock prices. Roborock's listing application was reviewed, and UBTECH ROBOTICS' stock price rose. Other tech stocks generally fell, while some AI stocks performed relatively well

    AASTOCKS·
    HK
    09880
    +8.78%
    SH
    688169
    +0.90%
    AASTOCKS·
    HK
    09880
    +8.78%
    SH
    688169
    +0.90%

    Trip.com, Regencell Bioscience, And Atlassian Are Among Top 10 Large Cap Losers Last Week (Jan. 12-Jan. 16): Are the Others in Your Portfolio?

    Trip.com, Regencell Bioscience, and Atlassian were among the top 10 large-cap losers last week, with Regencell leading the decline at 42.08%. Other notable losers included Figma (-19.41%), Atlassian (-19.82%), and Trip.com (-20.19%) due to downgrades and investigations. Analysts have adjusted price targets for several companies, including Morgan Stanley lowering Figma's target from $65 to $48 and HubSpot's from $640 to $577. Overall, the tech sector faced broader weakness, impacting multiple stocks significantly.

    benzinga_article·
    US
    TCOM
    +0.77%
    HK
    09961
    +1.03%
    US
    RGC
    -8.75%
    benzinga_article·
    US
    TCOM
    +0.77%
    HK
    09961
    +1.03%
    US
    RGC
    -8.75%

    How weight-loss drugs are destroying big snacking, erasing billions in sales

    The rise of GLP-1 weight-loss drugs is significantly impacting the food and beverage industry, leading to a projected $48 billion reduction in spending by 2034. Consumers are reducing their snacking frequency and appetite, with major brands like PepsiCo and Mondelez facing declining sales. Traditional marketing strategies are failing as appetite suppression alters consumer behavior, challenging the business models of companies reliant on high-volume sales. Fast-food spending has also dropped among GLP-1 users, indicating a fundamental shift in consumption patterns.

    Invezz·
    US
    PEP
    -0.17%
    US
    MDLZ
    -0.10%
    Invezz·
    US
    PEP
    -0.17%
    US
    MDLZ
    -0.10%

    The Nasdaq Biotechnology Index closed down more than 1.7%. Dyne's stock price fell 16.85%, Silence Therapeutics dropped 8.90%, Q32 Bio decreased 8.38%, and Summit Therapeutics Plc. fell 8.13%. Terns Pharmaceuticals rose 6.48%, Wave Life Sciences increased 14.58%, Applied Therapeutics gained 15.32%, and Cartesian Therapeutics climbed 18.08%

    Wallstreetcn·
    US
    SLN
    -9.35%
    US
    WVE
    -2.99%
    US
    APLT
    -1.57%
    Wallstreetcn·
    US
    SLN
    -9.35%
    US
    WVE
    -2.99%
    US
    APLT
    -1.57%

    U.S. stock night trading volatility: Q32 Bio fell 6.81% in night trading, with active capital flow triggering market volatility attention

    Q32 Bio fell 6.81% in after-hours trading; Janux Therapeutics fell 43.57% in after-hours trading, with a transaction volume of USD 250,400; BeiGene fell 1.14% in after-hours trading, with a transaction volume of USD 230,800; Recursion Pharmaceuticals rose 1.38% in after-hours trading, with a transaction volume of USD 196,200

    Tracking Unusual Activity·
    US
    QTTB
    0.00%
    Tracking Unusual Activity·
    US
    QTTB
    0.00%
    © 2026 Longbridge｜Disclaimer